BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 29800686)

  • 1. Beyond Gross Total and Subtotal: Does Volumetric Resection Matter in Nonfunctioning Pituitary Macroadenomas?
    Hughes JD; Koeller K; Rinaldo L; Erickson D; Bancos I; Meyer FB; Atkinson J; Van Gompel JJ
    World Neurosurg; 2018 Aug; 116():e733-e737. PubMed ID: 29800686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pituitary surgery and volumetric assessment of extent of resection: a paradigm shift in the use of intraoperative magnetic resonance imaging.
    Serra C; Burkhardt JK; Esposito G; Bozinov O; Pangalu A; Valavanis A; Holzmann D; Schmid C; Regli L
    Neurosurg Focus; 2016 Mar; 40(3):E17. PubMed ID: 26926057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of outcomes between a less experienced surgeon using a fully endoscopic technique and a very experienced surgeon using a microscopic transsphenoidal technique for pituitary adenoma.
    Zaidi HA; Awad AW; Bohl MA; Chapple K; Knecht L; Jahnke H; White WL; Little AS
    J Neurosurg; 2016 Mar; 124(3):596-604. PubMed ID: 26473774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endoscopic Endonasal Excision of Large and Giant Pituitary Adenomas: Radiological and Intraoperative Correlates of the Extent of Resection.
    Azab WA; Nasim K; Abdelnabi EA; Yousef W; Najibullah M; Khan T; Zaidan SN; Bokeris AA; Mostafa KH; Geng D
    World Neurosurg; 2019 Jun; 126():e793-e802. PubMed ID: 30857994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of extent of resection for recurrent glioblastoma on overall survival: clinical article.
    Bloch O; Han SJ; Cha S; Sun MZ; Aghi MK; McDermott MW; Berger MS; Parsa AT
    J Neurosurg; 2012 Dec; 117(6):1032-8. PubMed ID: 23039151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Residual tumor volume versus extent of resection: predictors of survival after surgery for glioblastoma.
    Grabowski MM; Recinos PF; Nowacki AS; Schroeder JL; Angelov L; Barnett GH; Vogelbaum MA
    J Neurosurg; 2014 Nov; 121(5):1115-23. PubMed ID: 25192475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Volumetric Analysis Using Low-Field Intraoperative Magnetic Resonance Imaging for 168 Newly Diagnosed Supratentorial Glioblastomas: Effects of Extent of Resection and Residual Tumor Volume on Survival and Recurrence.
    Fukui A; Muragaki Y; Saito T; Maruyama T; Nitta M; Ikuta S; Kawamata T
    World Neurosurg; 2017 Feb; 98():73-80. PubMed ID: 27989974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term results of endonasal endoscopic transsphenoidal resection of nonfunctioning pituitary macroadenomas.
    Dallapiazza RF; Grober Y; Starke RM; Laws ER; Jane JA
    Neurosurgery; 2015 Jan; 76(1):42-52; discussion 52-3. PubMed ID: 25255271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conditioned recurrence-free survival following gross-total resection of nonfunctioning pituitary adenoma: a single-surgeon, single-center retrospective study.
    McClure JJ; Chatrath A; Robison TR; Jane JA
    J Neurosurg; 2024 Jun; 140(6):1614-1619. PubMed ID: 38064693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of recurrence in solid nonfunctioning pituitary macroadenomas: additional benefits of diffusion-weighted MR imaging.
    Ko CC; Chen TY; Lim SW; Kuo YT; Wu TC; Chen JH
    J Neurosurg; 2019 Feb; 132(2):351-359. PubMed ID: 30717054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraoperative high-field MRI for transsphenoidal reoperations of nonfunctioning pituitary adenoma.
    Berkmann S; Schlaffer S; Nimsky C; Fahlbusch R; Buchfelder M
    J Neurosurg; 2014 Nov; 121(5):1166-75. PubMed ID: 25127413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary versus revision transsphenoidal resection for nonfunctioning pituitary macroadenomas: matched cohort study.
    Przybylowski CJ; Dallapiazza RF; Williams BJ; Pomeraniec IJ; Xu Z; Payne SC; Laws ER; Jane JA
    J Neurosurg; 2017 Mar; 126(3):889-896. PubMed ID: 27203142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proposal and Validation of a Simple Grading Scale (TRANSSPHER Grade) for Predicting Gross Total Resection of Nonfunctioning Pituitary Macroadenomas After Transsphenoidal Surgery.
    Mooney MA; Sarris CE; Zhou JJ; Barkhoudarian G; Chicoine MR; Fernandez-Miranda JC; Gardner PA; Hardesty DA; Jahnke H; Kelly DF; Liebelt BD; Mayberg MR; Prevedello DM; Sfondouris J; Sheehy JP; Chandler JP; Yuen KCJ; White WL; Little AS;
    Oper Neurosurg (Hagerstown); 2019 Nov; 17(5):460-469. PubMed ID: 30649445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determining the utility of intraoperative magnetic resonance imaging for transsphenoidal surgery: a retrospective study.
    Coburger J; König R; Seitz K; Bäzner U; Wirtz CR; Hlavac M
    J Neurosurg; 2014 Feb; 120(2):346-56. PubMed ID: 24329023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Both invasiveness and proliferation criteria predict recurrence of non-functioning pituitary macroadenomas after surgery: a retrospective analysis of a monocentric cohort of 120 patients.
    Lelotte J; Mourin A; Fomekong E; Michotte A; Raftopoulos C; Maiter D
    Eur J Endocrinol; 2018 Mar; 178(3):237-246. PubMed ID: 29259039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three-dimensional volumetric measurements in defining endoscope-guided giant adenoma surgery outcomes.
    Chohan MO; Levin AM; Singh R; Zhou Z; Green CL; Kazam JJ; Tsiouris AJ; Anand VK; Schwartz TH
    Pituitary; 2016 Jun; 19(3):311-21. PubMed ID: 26843023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-grade glioma surgery in eloquent areas: volumetric analysis of extent of resection and its impact on overall survival. A single-institution experience in 190 patients: clinical article.
    Ius T; Isola M; Budai R; Pauletto G; Tomasino B; Fadiga L; Skrap M
    J Neurosurg; 2012 Dec; 117(6):1039-52. PubMed ID: 23039150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endoscopic endonasal transsphenoidal approach to large and giant pituitary adenomas: institutional experience and predictors of extent of resection.
    Juraschka K; Khan OH; Godoy BL; Monsalves E; Kilian A; Krischek B; Ghare A; Vescan A; Gentili F; Zadeh G
    J Neurosurg; 2014 Jul; 121(1):75-83. PubMed ID: 24785323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of maximum safe resection of glioblastoma on survival in 1229 patients: Can we do better than gross-total resection?
    Li YM; Suki D; Hess K; Sawaya R
    J Neurosurg; 2016 Apr; 124(4):977-88. PubMed ID: 26495941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retrospective analysis of a concurrent series of microscopic versus endoscopic transsphenoidal surgeries for Knosp Grades 0-2 nonfunctioning pituitary macroadenomas at a single institution.
    Dallapiazza R; Bond AE; Grober Y; Louis RG; Payne SC; Oldfield EH; Jane JA
    J Neurosurg; 2014 Sep; 121(3):511-7. PubMed ID: 24995783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.